Risedronic acid
Risedronic acid Basic information
- Product Name:
- Risedronic acid
- Synonyms:
-
- 1-Hydroxy-2-(3-pyridyl)-ethan-1,1-bis-phosphonic acid
- RISEDRONIC ACID: RISEDRONIC ACID MONOHYDRATE
- 1-Hydroxy-2-(3-pyridinyl)ethylidenebisphosphonicacidmonohydrate
- 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE]BISPHOSPHONIC ACID
- 3-(Acetic acid)Pyridine
- Risedronic acid(Sodium risedronate intermediate)
- Phosphonic acid,P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-
- P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-phosphonic acid
- CAS:
- 105462-24-6
- MF:
- C7H11NO7P2
- MW:
- 283.11
- EINECS:
- 600-654-2
- Product Categories:
-
- API
- (intermediate of risedronate sodium
- Risedronate
- Mol File:
- 105462-24-6.mol
Risedronic acid Chemical Properties
- Melting point:
- >232°C (subl.)
- Boiling point:
- 692.3±65.0 °C(Predicted)
- Density
- 1.870±0.06 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- solubility
- Aqueous Base (Slightly), Methanol (Very Slightly, Heated, Sonicated)
- form
- Solid
- pka
- 1.41±0.10(Predicted)
- color
- White to Off-White
- Stability:
- Hygroscopic
- InChI
- InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
- InChIKey
- IIDJRNMFWXDHID-UHFFFAOYSA-N
- SMILES
- C(P(=O)(O)O)(P(=O)(O)O)(O)CC1=CC=CN=C1
- CAS DataBase Reference
- 105462-24-6(CAS DataBase Reference)
- EPA Substance Registry System
- Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis- (105462-24-6)
Safety Information
- Hazardous Substances Data
- 105462-24-6(Hazardous Substances Data)
Risedronic acid Usage And Synthesis
Uses
Risedronic Acid is a pyridinyl biphosphonate bone resorption inhibitor. It is a potentially useful biophosphonate for bone resorption analysis.
Definition
ChEBI: Risedronic acid is a member of pyridines. It is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease. It functions by preventing resorption of bone.
in vivo
Risedronic acid (Risedronate) (30 μg/kg; subcutaneous injection; once every other day; 3 weeks) prevents radiation-induced osteoporosis in female C57BL/6 mice irradiated with 2 Gy X-rays, inhibits trabecular bone loss and microstructural damage, and suppresses the increase in osteoclast number and serum TRAP5b2.
Risedronic acid (10-25 mg/kg; intraperitoneal injection; once a day; 7 days) inhibits parasitemia in BALB/c mice infected with?Plasmodium berghei?strain ANKA, but does not prolong the survival time of mice3.
| Animal Model: | Female C57BL/6 mice (20-week-old, ~23 g) irradiated with 2 Gy X-rays whole-body2 |
| Dosage: | 30 μg/kg |
| Administration: | Subcutaneous injection, once every other day, for 3 weeks |
| Result: | Prevented the radiation-induced increase in osteoclast number, surface, and TRAP5b. |
| Animal Model: | Male BALB/c mice (3-4 weeks old) infected with?Plasmodium berghei?strain ANKA by intraperitoneal injection of?1×106?blood-stage parasites3 |
| Dosage: | 10 mg/kg, 15 mg/kg, 20 mg/kg, 25 mg/kg |
| Administration: | Intraperitoneal injection, once a day, for 7 days |
| Result: | Led to an 88.9% inhibition of the rodent parasite Plasmodium berghei in mice on the seventh day of treatment. |
Mode of action
Risedronatic acid binds to bone hydroxyapatite. Bone resorption causes local acidification, releasing risedronic acid which is that taken into osteoclasts by fluid-phase endocytosis. Endocytic vesicles are acidified, releasing risedronic acid to the cytosol of osteoclasts where they induce apoptosis through inhbition of farnesyl pyrophosphate synthase. Inhibition of osteoclasts results in decreased bone resorption.
Risedronic acidSupplier
- Tel
- 0519-13912326059 13912326059
- alona1979@163.com
- Tel
- 021-50182298 021-50180596
- sales@boylechem.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
Risedronic acid(105462-24-6)Related Product Information
- Amino tris(methylene phosphonic acid)
- Stearic acid
- Ethanol
- Ethylparaben
- Folic acid
- Hyaluronic acid
- 1-Hydroxyethylidene-1,1-diphosphonic acid
- CHLOROPHOSPHONAZO III
- ISOXADIFEN-ETHYL
- Trinexapac-ethyl
- 2-Ethoxyethanol
- Ethyl acetate
- Zoledronic acid
- Disodium pamidronate
- Ethyl 2-(Chlorosulfonyl)acetate
- Citric acid
- Ascoric Acid
- Diethyl ether